By expenditures
| Name | Title | Type |
|---|---|---|
| Daniel Grimshaw | Director Of Finance | Auditee |
| Max Manley | Director | Auditee |
| James M. Larson | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 369362 | 2024 | 2025-09-30 | Cerini and Associates LLP | $2.44M |
| 322582 | 2023 | 2024-09-30 | Gelman Rosenberg & Freedman | $2.59M |
| 49794 | 2022 | 2023-07-31 | Gelman Rosenberg & Freedman | $1.93M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 322582 | 2023 | 2024-09-30 | 1076203 | 2023-003 | Significant Deficiency | - | H |
| 322582 | 2023 | 2024-09-30 | 1076202 | 2023-002 | Significant Deficiency | - | L |
| 322582 | 2023 | 2024-09-30 | 1076201 | 2023-003 | Significant Deficiency | - | H |
| 322582 | 2023 | 2024-09-30 | 1076200 | 2023-002 | Significant Deficiency | - | L |
| 322582 | 2023 | 2024-09-30 | 1076199 | 2023-003 | Significant Deficiency | - | H |
| 322582 | 2023 | 2024-09-30 | 1076198 | 2023-002 | Significant Deficiency | - | L |
| 322582 | 2023 | 2024-09-30 | 1076197 | 2023-003 | Significant Deficiency | - | H |
| 322582 | 2023 | 2024-09-30 | 1076196 | 2023-002 | Significant Deficiency | - | L |
| 322582 | 2023 | 2024-09-30 | 499761 | 2023-003 | Significant Deficiency | - | H |
| 322582 | 2023 | 2024-09-30 | 499760 | 2023-002 | Significant Deficiency | - | L |
| 322582 | 2023 | 2024-09-30 | 499759 | 2023-003 | Significant Deficiency | - | H |
| 322582 | 2023 | 2024-09-30 | 499758 | 2023-002 | Significant Deficiency | - | L |
| 322582 | 2023 | 2024-09-30 | 499757 | 2023-003 | Significant Deficiency | - | H |
| 322582 | 2023 | 2024-09-30 | 499756 | 2023-002 | Significant Deficiency | - | L |
| 322582 | 2023 | 2024-09-30 | 499755 | 2023-003 | Significant Deficiency | - | H |
| 322582 | 2023 | 2024-09-30 | 499754 | 2023-002 | Significant Deficiency | - | L |
| 49794 | 2022 | 2023-07-31 | 625195 | 2022-001 | Significant Deficiency | - | B |
| 49794 | 2022 | 2023-07-31 | 625194 | 2022-001 | Significant Deficiency | - | B |
| 49794 | 2022 | 2023-07-31 | 625193 | 2022-001 | Significant Deficiency | - | B |
| 49794 | 2022 | 2023-07-31 | 625192 | 2022-001 | Significant Deficiency | - | B |
| 49794 | 2022 | 2023-07-31 | 48753 | 2022-001 | Significant Deficiency | - | B |
| 49794 | 2022 | 2023-07-31 | 48752 | 2022-001 | Significant Deficiency | - | B |
| 49794 | 2022 | 2023-07-31 | 48751 | 2022-001 | Significant Deficiency | - | B |
| 49794 | 2022 | 2023-07-31 | 48750 | 2022-001 | Significant Deficiency | - | B |